RUBEÓLA Y SÍNDROME DE RUBEÓLA CONGÉNITA: EPIDEMIOLOGÍA Y SITUACIÓN EN LATINOAMÉRICA
RUBEÓLA Y SÍNDROME DE RUBEÓLA CONGÉNITA
DOI:
https://doi.org/10.47230/unesum-ciencias.v4.n1.2021.335Keywords:
Epidemiology, rubella, cousin infection, Latin America; VirusAbstract
Rubella is a benign transferable exanthematic disease that has spread throughout the world, and is also known as German Measles. This is caused by the rubella virus that possesses a single stranded RNA of the family Togaviridae genus Rubivirus, and is found only in humans as natural hosts. This disease is usually quite mild in adults and children. However, it is dangerous when a pregnant woman (mainly during the first and second trimesters) suffers the primary infection, which constitutes a risk for the baby's living conditions, possibly developing Congenital Rubella Syndrome (CRS), which can result in disabilities serious for the fetus or neonate. This document seeks to examine the situation and scientific advances of the epidemiological surveillance of Rubella and CRS Congenital Rubella Syndrome in Latin America, reported in descriptive and exploratory studies. This review used the systematic and meta-analysis method (PRISMA), through an exhaustive search in the Scopus, NICE, Google Scholar and BMC Medidicine databases for articles published between 2009 and 2020. 376 documents of of which 28 met the criteria, 8 of these were rejected, 3 duplicates and 17 accepted. It was recorded that with fines in 2015, the World Health Organization WHO proclaimed the Region of the Americas free of endemic rubella transmission.
Downloads
References
Absalem, A. A., Alanazi, R. M., Alkhawajah, S. H., Hijazi, O. A., Jarad, F. A., Alrowaithi, B. H., Hussein, Z. J., & Adam, A. B. S. (2017). Rubella and Congenital Rubella Syndrome in Pediatric. The Egyptian Journal of Hospital Medicine, 69(3), 2075-2081. https://journals.ekb.eg/article_11805_3f95a848b12fdb9fee5fd8fa1520c1a5.pdf
Bejarano Arcos, A. V. (2017). Inmunidad frente a rubéola mediante resultados de anticuerpos IgG en pacientes gestantes, que acudieron al Hospital “Un Canto a la Vida” en el periodo de enero 2014 a diciembre del 2016 Quito: UCE]. http://www.dspace.uce.edu.ec:8080/bitstream/25000/11608/1/T-UCE-0006-008-2017.pdf
Bernal, C. (2010). Metodología de la investigación. Tercera edición PEARSON EDUCACIÓN. Colombia ISBN, 978-958.
Castillo-Solórzano, C., & Quadros, C. A. d. (2002). Control acelerado de la rubéola y prevención del síndrome de rubéola congénita en las Américas. Revista Panamericana de Salud Pública, 11, 273-276. https://www.scielosp.org/article/rpsp/2002.v11n4/273-276/es/
Cutts, F., & Vynnycky, E. (1999). Modelling the incidence of congenital rubella syndrome in developing countries. International journal of epidemiology, 28(6), 1176-1184. https://academic.oup.com/ije/article-pdf/28/6/1176/18477814/281176.pdf
Francisco, P. M. S. B., Senicato, C., Donalisio, M. R., & Barros, M. B. d. A. (2013). Vacinação contra rubéola em mulheres em idade reprodutiva no Município de Campinas, São Paulo, Brasil. Cadernos de Saúde Pública, 29, 579-588. https://www.scielosp.org/article/csp/2013.v29n3/579-588/
García León, M. L., & Wong Chew, R. M. (2018). La vacuna contra la rubéola produce una respuesta inmune combinada celular y humoral en adultos. Asociación Mexicana de Infectología y Microbiología, 38(3), 72. http://www.amimc.org.mx/wp-content/uploads/2018/12/EIM3-2018.pdf#page=6
Guzmán, T. J. C., Dávila, T. G. C., & Ochoa, P. A. G. (2015). Títulos de anticuerpos protectores contra la Rubeola en adolescentes de colegios urbano y rural de la ciudad de Loja. CEDAMAZ, 5(1). https://revistas.unl.edu.ec/index.php/cedamaz/article/download/45/43
Hinman, A. R., Irons, B., Lewis, M., & Kandola, K. (2002). Economic analyses of rubella and rubella vaccines: a global review. Bulletin of the World Health Organization, 80, 264-270. https://www.scielosp.org/article/bwho/2002.v80n4/264-270/en/
Mar, O., Véliz, Y. Z., Felipe, M. d. R. C., & Vázquez, M. L. (2015). Motor de inferencia decisional en sistema informático para la evaluación del desempeño. Revista Cubana de Ciencias Informáticas,9(4), 16-29.
Martínez-Quintana, E., Castillo-Solórzano, C., Torner, N., & Rodríguez-González, F. (2015). Congenital rubella syndrome: a matter of concern. Revista Panamericana de Salud Pública, 37, 179-186. https://www.scielosp.org/article/rpsp/2015.v37n3/179-186/pt/
Montoya, R. F., Arias, A. B., & González, B. L. (2018). Síndrome de rubeola congénita. Presentación de un caso. Multimed, 22(3), 671-681. http://www.revmultimed.sld.cu/index.php/mtm/article/download/908/1385
Moraes, M. M., Cruz, A. C. R., Silva, D. d. F. L., & Oliveira Santos, E. C. (2015). Trajetória da rubéola no Estado do Pará, Brasil: rumo à erradicação. Revista Pan-Amazônica de Saúde, 6(1), 10-10. http://revista.iec.gov.br/submit/index.php/rpas/article/download/288/127
Oficial, R. (2014). Código Orgánico Integral Penal.
Pardón, F. (2014). Diagnóstico molecular de virus rubéola en el Instituto Nacional de Enfermedades Infecciosas ANLIS Dr. Carlos G. Malbrán 2003-2012. http://repositorio.anlis.gov.ar/xmlui/bitstream/123456789/577/1/T_MMM_Pardon.pdf
Peñafiel Cruz, B. A., & Moreira De la Cruz, L. P. (2020). RUBÉOLA Y SÍNDROME DE RUBÉOLA CONGÉNITA: EPIDEMIOLOGÍA Y SITUACIÓN EN LATINOAMÉRICA Jipijapa. UNESUM]. http://repositorio.unesum.edu.ec/bitstream/53000/2536/1/PE%C3%91AFIELCRUZ-MOERIRA%20DE%20LA%20CRUZ.pdf
Salamanca-Rojas, S., Barahona-López, N. M., Marín-Valcárcel, A., Vidal-Camargo, P. A., Pedraza-Bernal, A. M., Ramírez-Rueda, R. Y., & Jaimes-Bernal, C. P. (2018). Seroprevalencia de anticuerpos IgG antirubéola y anticitomegalovirus en mujeres entre 16 y 40 años residentes en Tunja, Colombia. Revista de Salud Pública, 20, 479-483. https://www.scielosp.org/article/rsap/2018.v20n4/479-483/pt/
Salazar Madrigal, K. A. (2018). Vacuna contra sarampión rubeola y paperas y su asociación con autismo: a 20 años de controversia. Revista Costarricense de Salud Pública, 27(1), 79-86. https://www.scielo.sa.cr/scielo.php?pid=S1409-14292018000100079&script=sci_arttext
Sampaio, R. F., & Mancini, M. C. (2007). Systematic review studies: a guide for careful synthesis of the scientific evidence. Brazilian Journal of Physical Therapy, 11(1), 83-89. https://www.scielo.br/pdf/rbfis/v11n1/12
Seguro Social, C. C. (2015). Protocolo de Vigilancia Epidemiológica para sarampión y rubéola. https://repositorio.binasss.sa.cr/repositorio/bitstream/handle/20.500.11764/642/protocolosarampion.pdf?sequence=1&isAllowed=y
Teglia, O. F. (2019). Sarampión y rubeola. Retrieved 2 from http://revistamedicaderosario.org/index.php/rm/article/view/20
UNICEF. (2019). Acción humanitaria para la infancia. https://www.unicef.org/es/informes/acci%C3%B3n-humanitaria-para-la-infancia-2019-resumen
Van den Boogaard, J., Gier, B., & Lima, P. (2019). Systematic literature review and meta-analyses of the immunogenicity, duration of protection, effectiveness/efficacy and safety of rubella vaccination. https://www.who.int/immunization/sage/meetings/2019/october/4_Rubella_Vaccine_Systematic_Review_20190915.pdf
